Kathryn E. Wellen
凯瑟琳·韦伦
PhD
Professor of Cancer Biology癌症生物学教授
👥Biography 个人简介
Kathryn Wellen, PhD is a Professor at the University of Pennsylvania whose research illuminates how intracellular acetyl-CoA levels couple cellular metabolism to epigenetic gene regulation via histone acetylation. Her work has defined how nutrient availability — particularly glucose — influences chromatin state and gene expression in cancer and metabolic disease.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Acetyl-CoA and Histone Acetylation
Demonstrated that nuclear acetyl-CoA, derived from glucose via ATP-citrate lyase (ACLY), directly controls histone acetylation levels and regulates gene expression in response to nutrient availability.
Obesity-Cancer Metabolic Link
Characterized how obesity-associated metabolic changes alter acetyl-CoA pools and epigenetic states, providing mechanistic insight into obesity as a cancer risk factor.
Representative Works 代表性著作
ATP-citrate lyase links cellular metabolism to histone acetylation
Science (2009)
Landmark discovery showing that ACLY-derived nuclear acetyl-CoA controls histone acetylation, directly linking metabolism to epigenetic regulation.
Metabolic regulation of transcription through compartmentalized acetyl-CoA metabolism
Science (2022)
Resolved how spatial control of acetyl-CoA pools enables distinct transcriptional programs in different cellular compartments.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Faisal Mahmood
Brigham and Women's Hospital; Harvard Medical School
Kun-Hsing Yu
Harvard Medical School; Brigham and Women's Hospital
Ziad Obermeyer
University of California, Berkeley; UC San Francisco
Andrew H. Beck
PathAI; Harvard Medical School (formerly)
关注 凯瑟琳·韦伦 的研究动态
Follow Kathryn E. Wellen's research updates
留下邮箱,当我们发布与 Kathryn E. Wellen(University of Pennsylvania Perelman School of Medicine)相关的新研究或访谈时,我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment